首页> 美国卫生研究院文献>The EPMA Journal >Specific protein biomarker patterns for Alzheimer’s disease: improved diagnostics in progress
【2h】

Specific protein biomarker patterns for Alzheimer’s disease: improved diagnostics in progress

机译:阿尔茨海默氏病的特定蛋白质生物标记物模式:正在进行的诊断改进

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This short review looks at Alzheimer’s disease (AD) diagnosis through my own point of view, going from imaging through cerebrospinal fluid to blood proteins. Over the last couple of years, we have published two papers targeted at Alzheimer’s diagnosis. In one paper, we took an approach of selecting a specific target, namely, activity-dependent neuroprotective protein (ADNP), and our results tightened the association of ADNP blood expression with intelligence. In another paper, we took an unbiased approach of analysis of all genes expressed in lymphoblastoid cells lines and discovered changes in expression of the regulator of G-protein signaling 2 (RGS2) as a potential AD predictor. This review will assess our data in comparison to selected independent studies focusing on blood protein biomarkers as well as assessing saliva and urine samples with potential predictive value for AD. Furthermore, the review will provide directions for a combination of innovative markers, stratifying the population toward disease prevention and personalized medicine.
机译:这篇简短的评论从我自己的观点出发,从成像到脑脊髓液再到血液蛋白,着眼于阿尔茨海默氏病(AD)的诊断。在过去的几年中,我们发表了两篇针对阿尔茨海默氏病诊断的论文。在一篇论文中,我们采用了一种选择特定靶标的方法,即活性依赖性神经保护蛋白(ADNP),我们的结果加强了ADNP血液表达与智力的关联。在另一篇论文中,我们采用了一种无偏见的方法来分析在淋巴母细胞细胞系中表达的所有基因,并发现了G蛋白信号传导2(RGS2)调节剂作为潜在的AD预测因子的表达发生了变化。这篇综述将评估我们的数据,并与针对血液蛋白生物标志物的选定独立研究进行比较,以及评估对AD具有潜在预测价值的唾液和尿液样本。此外,该评论将为创新标记的组合提供指导,将人群分为疾病预防和个性化医学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号